Screener
International Flavors & Fragrances IFF Health & Biosciences — Foreign exchange
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by International Flavors & Fragrances in its filing.
Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.
The source filing: International Flavors & Fragrances’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:24 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000051253-26-000017
FAQ
- What is International Flavors & Fragrances's health & biosciences — foreign exchange?
- International Flavors & Fragrances (IFF) reported health & biosciences — foreign exchange of -$22M in Q1 2026.
- How has International Flavors & Fragrances's health & biosciences — foreign exchange changed year-over-year?
- International Flavors & Fragrances's health & biosciences — foreign exchange decreased by 136.7% year-over-year, from $60M to -$22M.
- What is the long-term trend for International Flavors & Fragrances's health & biosciences — foreign exchange?
- Over 2 years (2023 to 2025), International Flavors & Fragrances's health & biosciences — foreign exchange has grown at a 84.7% compound annual growth rate (CAGR), from $56M to $191M.
- What does health & biosciences — foreign exchange mean?
- The impact of currency fluctuations on the financial results of the Health & Biosciences segment, resulting from operations in international markets. This captures gains or losses from translating foreign currency-denominated transactions into the reporting currency.
Ask your AI about International Flavors & Fragrances's health & biosciences — foreign exchange.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude